Skip to content

EASE MITRAL Expertise-based Assessment Study on Clinical Efficacy of Profile 3D in MITRAL Valve Annuloplasty

EASE MITRAL Expertise-based Assessment Study on Clinical Efficacy of Profile 3D in MITRAL Valve Annuloplasty

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01112566
Enrollment
152
Registered
2010-04-28
Start date
2013-02-28
Completion date
2017-05-31
Last updated
2018-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Valve Insufficiency

Brief summary

The goal of the study is to identify the patients suffering from a mitral valve condition who benefit from the implantation of a Profile 3D annuloplasty ring in terms of acute and long-term relief of mitral valve regurgitation.

Interventions

None listed

Sponsors

Medtronic Cardiac Rhythm and Heart Failure
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Indicated for a surgical repair for moderate to severe mitral valve regurgitation at rest (level 2 or higher); * Willing to return to the hospital where the implantation originally occurred as part of the standard practice of care

Exclusion criteria

* Heavily calcified valves * Valvular retraction with severely reduced mobility * Active bacterial endocarditis * Already participating in another investigational device study, possibly leading to bias and jeopardizing the scientific appropriate assessment of the study endpoints; * Life expectancy of less than one year; * Pregnant or desire to be pregnant within 12 months of the study treatment; * Under 18 years or over 85 years of age.

Design outcomes

Primary

MeasureTime frame
Identify the patient population for which a Profile 3D Annuloplasty Ring is chosen to repair the mitral valve insufficiency.screening
Assess the percentage of patients that are chronically relieved from mitral valve dysfunction6-12 months follow up
Determine the level of mitral valve regurgitation in patients6-12 months post-surgery

Countries

Canada, Czechia, France, Germany, Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026